Fragmentation Pattern of Fibrinogen During Thrombolysis in Acute Myocardial Infarction with Fibrin-Specific Plasminogen Activators - Detection of High-Molecular Weight Fibrinogen Degradation Products

[1]  R. Dietz,et al.  An accelerated “frontloaded” RT-PA thrombolysis regimen achives higher TIMI III patency rates in acute myocardial infarction , 1994 .

[2]  Frans Van de Werf,et al.  An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. , 1993, The New England journal of medicine.

[3]  U. Tebbe,et al.  Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study (TAPS) , 1992, Journal of the American College of Cardiology.

[4]  David Hunt,et al.  ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION , 1992 .

[5]  W. Nieuwenhuizen,et al.  A Quantitative Enzyme Immunoassay for Primary Fibrinogenolysis Products in Plasma , 1987, Thrombosis and Haemostasis.

[6]  W. Nieuwenhuizen,et al.  New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody. , 1987, The Journal of laboratory and clinical medicine.

[7]  D. Collen,et al.  Pharmacokinetics and systemic fibrinogenolytic effects of recombinant human tissue-type plasminogen activator (rt-PA) in humans. , 1985, The Journal of pharmacology and experimental therapeutics.

[8]  G. Claeson,et al.  Methods for the Determination of Plasmin, Antiplasmin and Plasminogen by Means of the Substrate S-2251 , 1977, Thrombosis and Haemostasis.

[9]  D. Kosow,et al.  Kinetic mechanism of the activation of human plasminogen by streptokinase. , 1975, Biochemistry.

[10]  Y. Nemerson.  Thrombosis and Bleeding Disorders , 1971, The Yale Journal of Biology and Medicine.

[11]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[12]  A. Fletcher,et al.  The proteolysis of fibrinogen by plasmin: the identification of thrombin-clottable fibrinogen derivatives which polymerize abnormally. , 1966, The Journal of laboratory and clinical medicine.

[13]  A. Fletcher,et al.  THE DEVELOPMENT OF UROKINASE AS A THROMBOLYTIC AGENT. MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN BY ITS INTRAVENOUS INFUSION. , 1965, The Journal of laboratory and clinical medicine.

[14]  A. Fletcher,et al.  Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products. , 1962, The Journal of clinical investigation.